Episode
Cancer Jab Vanishes Tumors in Hard-to-Treat Cases
- Published
- May 30, 2026
- Duration seconds
- 112
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/uk-news-today-2-min-news-the-daily-news-now-7493829/episodes/cancer-jab-vanishes-tumors-in-hard-to-treat-cases/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/uk-news-today-2-min-news-the-daily-news-now-7493829/cancer-jab-vanishes-tumors-in-hard-to-treat-cases.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Scientists just dropped a game-changer: a new cancer jab called amivantamab wiped out tumors in 15 patients with advanced, treatment-resistant head and neck cancer — some even completely vanished. This triple-action drug works by blocking growth, stopping escape routes, and revving up the immune system. In a trial of over 100 patients, more than a third saw tumors shrink, and survivors lived over 12 months on average. Patients report dramatic improvements — one regained the ability to eat and speak normally. Administered under the skin, it’s far easier than IV treatments, with mostly mild side effects. Experts call the results unprecedented — especially for HPV-negative cancers, which are notoriously hard to treat. This breakthrough shines a light on the power of relentless cancer research and offers hope to those with few options left. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/29483218cf8a4bac